IP Library Granted Patent US 9,797,909
Granted Patent B2
US 9,797,909 · App. 15/276,428 · Granted Oct 24, 2017

Sensor

Inventors: William Paterson (Oxforshire, GB); Nick Barwell (Coventry, GB); Bruce Culbert (Bucks, GB); Barry Colin Crane (Oxfordshire, GB)
Assignee: Lightship Medical Limited
G01N33/66A61B5/1459A61B5/14532A61B5/14735G01N21/6428G01N21/7703G01N33/542G01N33/54366G01N33/84Y10T436/144444Y10T436/206664Y10T436/255
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,797,909
App. No.
15/276,428
Granted
Oct 24, 2017
Kind
B2
Abstract

A sensor for detecting and/or quantifying the amount of analyte in a sample, the sensor including: a sensing region; and a barrier layer including a reactive oxygen species (ROS)-quenching, analyte-permeable membrane having an ROS-quenching agent adsorbed thereto; wherein the sensor is adapted so that the sample enters the sensing region of the sensor through the barrier layer.

Claims (41)

1. A sensor comprising:

a sensing region;

a porous barrier layer; and

a reactive oxygen species (ROS)-quenching agent formed on or in the barrier layer;

wherein the sensing region of the sensor defines one or more openings to allow an analyte in a bodily fluid sample to enter the sensing region;

wherein the barrier layer is disposed across the one or more openings to allow the analyte to enter the sensing region through the barrier layer such that the analyte comes into contact with the ROS-quenching agent;

wherein the barrier layer has an ROS-quenching activity sufficient to quench a solution of H 2 O 2 having a concentration of 10 ppm; and

wherein the sensor is configured such that fluid passing through the barrier layer is in contact with the ROS-quenching agent throughout the time the fluid is moving through the barrier layer.

2. The sensor of claim 1 , wherein the ROS-quenching agent comprises platinum.

3. The sensor of claim 2 , wherein the ROS-quenching agent comprises platinum in the form of nanoparticles.

4. The sensor of claim 1 , wherein an entire sensing region, or an entire surface of the sensor that comes into contact with the sample, is coated or sheathed with the barrier layer.

5. The sensor of claim 1 , wherein the barrier layer comprises polypropylene hollow fibres.

6. The sensor of claim 1 , wherein the sensing region is provided on a support material.

7. The sensor of claim 1 , wherein the barrier layer is provided over the entire sensing region or is provided on only part of the sensing region.

8. A sensor comprising:

a sensing region; and

a porous barrier layer comprising an ROS-quenching agent;

wherein the sensing region of the sensor defines one or more openings to allow an analyte in a bodily fluid sample to enter the sensing region; and

wherein the barrier layer is disposed across the one or more openings to allow the analyte to enter the sensing region through the barrier layer such that the analyte comes into contact with the ROS-quenching agent;

wherein the barrier layer has an ROS-quenching activity sufficient to quench a solution of H 2 O 2 having a concentration of at least 10 ppm; and

wherein the sensor is configured such that fluid passing through the barrier layer is in contact with the ROS-quenching agent throughout the time the fluid is moving through the barrier layer.

9. The sensor of claim 8 , wherein the barrier layer is impregnated with the ROS-quenching agent.

10. The sensor of claim 8 , wherein the barrier layer comprises platinum in the form of nanoparticles.

11. The sensor of claim 8 , wherein the barrier layer is applied directly onto the sensing region.

12. The sensor of claim 8 , wherein the barrier layer substantially does not cause depletion of analyte.

13. The sensor of claim 8 , wherein sensing region comprises a receptor and a fluorophore that are bound to one another and to a polymeric matrix.

14. The sensor of claim 8 , wherein the sensing region is provided on a support material.

15. The sensor of claim 8 , wherein the barrier layer defines pores that have a pore size ranging from about 1 nm to 1 μm and an aspect ratio of at least 100.

16. The sensor of claim 8 , wherein the barrier layer defines pores, the pores each having a length, and the ROS-quenching agent is within the pores of the barrier layer and is distributed along the length of the pores.

17. The sensor of claim 8 , wherein the barrier layer is a layer formed by vapour deposition of the ROS-quenching agent.

18. The sensor of claim 8 , wherein the barrier layer does not allow materials of molecular weight 6,000 or higher to pass through.

19. The sensor of claim 8 , wherein the ROS-quenching agent is present at a loading of 0.01 to 5 wt % of the barrier layer.

20. The sensor of claim 8 , wherein the barrier layer has an ROS-quenching activity sufficient to quench a solution of H 2 O 2 having a concentration of 100 ppm.

21. The sensor of claim 8 , wherein the barrier layer is provided over the entire sensing region or is provided on only part of the sensing region.

22. A sensor comprising:

a sensing region;

a porous barrier layer; and

an ROS-quenching agent formed on or in the barrier layer;

wherein the sensing region of the sensor defines one or more openings to allow an analyte in a bodily fluid sample to enter the sensing region;

wherein the barrier layer is disposed across the one or more openings to allow the analyte to enter the sensing region through the barrier layer such that the analyte comes into contact with the ROS-quenching agent; and

wherein the sensor is configured such that fluid passing through the barrier layer is in contact with the ROS-quenching agent throughout the time the fluid is moving through the barrier layer.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074042/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 074046/0139 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2019
From: LIGHTSHIP MEDICAL LIMITED
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 048822/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2017
From: PATERSON, WILLIAM; BARWELL, NICK; CULBERT, BRUCE; CRANE, BARRY COLIN
To: LIGHTSHIP MEDICAL LIMITED
Reel/Frame 042870/0705 →
Continuity (5)
Continuation 14605315 · Jan 26, 2015
Continuation 14048364 · Oct 8, 2013
Continuation PCTGB2013050407 · Feb 20, 2013
Provisional Application 61611239 · Mar 15, 2012
Related Publication 20170010274A1 · Jan 12, 2017